Chiun‐Sheng Huang

机构：National Taiwan University, Taipei Veterans General Hospital, National Taiwan University Hospital · ORCID：0000-0002-6557-211X

发表论文 534 篇 · 总被引 29402 次 · h-index 65

代表论文

• Overall survival with abemaciclib in early breast cancer (2025 · Annals of Oncology · 被引 53)
• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (2025 · New England Journal of Medicine · 被引 50)
• Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025 · ESMO Open · 被引 37)
• Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer (2025 · JAMA Oncology · 被引 22)
• Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial (2025 · Annals of Oncology · 被引 18)
• Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial (2026 · Annals of Oncology · 被引 12)